| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +328K | 83.9% | $0.42 | +$138K |
| Sells | 1 | -63K | 16.1% | $0.35 | -$22.1K |
| Net | 0 | +265K | 67.8% | +$116K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Sankesh Abbhi | Director | $3.86M | Dec 10, 2021 | ||
| Ralph Kern | COO and Chief Medical Officer | $396K | Mar 6, 2022 | ||
| Malcolm Taub | Director | $137K | Dec 15, 2021 | ||
| Chaim Lebovits | President & CEO | $76.2K | +$138K | Jan 1, 2025 | |
| Kirk Taylor | Chief Medical Officer | $62.1K | May 1, 2023 | ||
| June Almenoff | Director | $23.4K | Dec 15, 2021 | ||
| Ibrahim B. Dagher | Chief Medical Officer | $18.1K | -$22.1K | -54.9% | Jan 1, 2025 |
| Uri Yablonka | EVP & Chief Business Officer, Director | $15.6K | Jan 1, 2025 | ||
| Hartoun Hartounian | EVP, Chief Operating Officer | $11.9K | Jan 1, 2025 | ||
| Stacy Lindborg | Director | $11K | Jan 1, 2025 | ||
| Alla Patlis | Interim Chief Financial Officer & Controller | $10.1K | Jan 1, 2025 | ||
| Jacob A. Frenkel | Director | $9.98K | Jan 1, 2025 | ||
| Irit Arbel | Director | $9.36K | Jan 1, 2025 | ||
| Nir Naor | Director | $7.17K | Jan 1, 2025 | ||
| Anthony J. Polverino | Director | $5.87K | Jan 1, 2025 | ||
| Menghisteab Bairu | Director | $5.47K | Jan 1, 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|